Girish S. Kulkarni

Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study

Arjun Vasant Balar, Ashish M. Kamat, Girish S. Kulkarni et al. · The Lancet Oncology · 2021 · 513 citations

Urology, Surgical Oncology, Genitourinary Cancer +7

Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic

Girish S. Kulkarni, Thomas Hermanns, Yanliang Wei et al. · Journal of Clinical Oncology · 2017 · 295 citations · Full text

Tmt Group, Urology, Surgical Oncology +15

Metformin Use and All-Cause and Prostate Cancer–Specific Mortality Among Men With Diabetes

David Margel, David R. Urbach, Lorraine L. Lipscombe et al. · Journal of Clinical Oncology · 2013 · 266 citations · Full text

Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis

Alexandre R. Zlotta, Leslie K. Ballas, Andrzej Niemierko et al. · The Lancet Oncology · 2023 · 223 citations

Urological Research, Urology, Surgical Oncology +7

Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study

Robert K. Nam, Patrick Cheung, Sender Herschorn et al. · The Lancet Oncology · 2014 · 220 citations

Urology, Surgical Oncology, Erectile Dysfunction +6